PE20061414A1 - Sistema terapeutico transdermico solido con absorbedor uv - Google Patents

Sistema terapeutico transdermico solido con absorbedor uv

Info

Publication number
PE20061414A1
PE20061414A1 PE2006000451A PE2006000451A PE20061414A1 PE 20061414 A1 PE20061414 A1 PE 20061414A1 PE 2006000451 A PE2006000451 A PE 2006000451A PE 2006000451 A PE2006000451 A PE 2006000451A PE 20061414 A1 PE20061414 A1 PE 20061414A1
Authority
PE
Peru
Prior art keywords
layer
absorber
active substance
base layer
matrix
Prior art date
Application number
PE2006000451A
Other languages
English (en)
Inventor
Thomas Langguth
Stefan Bracht
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of PE20061414A1 publication Critical patent/PE20061414A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

REFERIDA A UN SISTEMA TRANSDERMICO SOLIDO CON ABSORBEDOR UV QUE COMPRENDE AL MENOS TRES CAPAS SUCESIVAS, SIENDO LA MAS ALEJADA DE LA PIEL UNA CAPA BASE, LUEGO UNA MATRIZ Y UNA PELICULA PROTECTORA DESPRENDIBLE Y OPCIONALMENTE INTERCALADAS ENTRE LA CAPA DE BASE Y LA MATRIZ QUE CONTIENE UNA SUSTANCIA ACTIVA, UNA CAPA ADHESIVA Y EN DIRECCION DE LA MATRIZ QUE CONTIENE LA SUSTANCIA ACTIVA, UNA SIGUIENTE CAPA SEPARADORA CARACTERIZADA PORQUE EL O LOS ABSORBEDORES UV DEL GRUPO DE LAS HIDROXIFENILTRIAZINAS ESTAN INCORPORADOS EN LA CAPA BASE O EN LA CAPA ADHESIVA. EL ABSORBEDOR UV ES 2,4-BIS-i[4-(2-ETIL-HEXILOXI)-2-HIDROXI]-FENIL-6-(4-METOXIFENIL)-(1,3,5)TRIAZINA; LA CAPA MATRIZ Y/O LA LA CAPA ADHESIVA ES O SON DE POLIMEROS TALES COMO POLIISOBUTENO, POLIBUTENO, POLIACRILATO, ENTRE OTROS; LA CAPA SEPARADORA ES DE UN POLIMERO DE BARRERA DE TEREFTALATO DE POLIETILENO, POLIACRILNITRILO, CLORURO DE POLIVINILO, ENTRE OTROS; LA CAPA BASE ES PERMEABLE A LA SUSTANCIA ACTIVA Y ES DE POLIPROPILENO, POLIETILENO, COPOLIMERO DE ETILENO-VINILACETATO, ENTRE OTROS; Y LA SUSTANCIA ACTIVA ES UNA HORMONA TAL COMO GESTAGENO, DE PREFERENCIA, GESTODEN O LEVONOGESTREL. DICHO SISTEMA ES UTIL EN EL CONTROL DE LA FERTILIDAD
PE2006000451A 2005-05-02 2006-04-28 Sistema terapeutico transdermico solido con absorbedor uv PE20061414A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05009579A EP1719504A1 (de) 2005-05-02 2005-05-02 Festes transdermales therapeutisches System mit UV-Absorber

Publications (1)

Publication Number Publication Date
PE20061414A1 true PE20061414A1 (es) 2007-01-26

Family

ID=34981458

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2006000451A PE20061414A1 (es) 2005-05-02 2006-04-28 Sistema terapeutico transdermico solido con absorbedor uv

Country Status (26)

Country Link
EP (2) EP1719504A1 (es)
JP (2) JP5360877B2 (es)
KR (2) KR101351161B1 (es)
CN (2) CN101171001A (es)
AR (1) AR055927A1 (es)
AU (1) AU2006243442A1 (es)
BR (1) BRPI0611087A2 (es)
CA (1) CA2605112C (es)
CR (1) CR9483A (es)
CY (1) CY1115757T1 (es)
DK (1) DK1879560T3 (es)
DO (1) DOP2006000100A (es)
EA (1) EA200702344A1 (es)
ES (1) ES2523663T3 (es)
GT (1) GT200600183A (es)
IL (1) IL186945A0 (es)
MX (1) MX2007013779A (es)
NO (1) NO20076187L (es)
PE (1) PE20061414A1 (es)
PL (1) PL1879560T3 (es)
PT (1) PT1879560E (es)
SI (1) SI1879560T1 (es)
TW (1) TW200719902A (es)
UY (1) UY29511A1 (es)
WO (1) WO2006117139A2 (es)
ZA (1) ZA200710418B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2515918C (en) 2003-02-21 2010-11-16 Schering Ag Uv stable transdermal therapeutic plaster
US8668925B2 (en) 2003-12-12 2014-03-11 Bayer Intellectual Property Gmbh Transdermal delivery of hormones without the need of penetration enhancers
US8962013B2 (en) 2005-05-02 2015-02-24 Bayer Intellectual Property Gmbh Multi-layered transdermal system with triazine UV absorber
WO2012031999A2 (en) * 2010-09-06 2012-03-15 Bayer Pharma Aktiengesellschaft Low-dose transdermal patches with high drug release

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5023084A (en) * 1986-12-29 1991-06-11 Rutgers, The State University Of New Jersey Transdermal estrogen/progestin dosage unit, system and process
DE59107052D1 (de) * 1990-03-30 1996-01-25 Ciba Geigy Ag Lackzusammensetzungen
US8173592B1 (en) * 1999-03-31 2012-05-08 Zentaris Ivf Gmbh Method for a programmed controlled ovarian stimulation protocol
US7384650B2 (en) * 1999-11-24 2008-06-10 Agile Therapeutics, Inc. Skin permeation enhancement composition for transdermal hormone delivery system
EP1269999B1 (en) * 2000-03-17 2013-05-01 Hisamitsu Pharmaceutical Co. Inc. Ultraviolet-shielding patch
CA2515918C (en) * 2003-02-21 2010-11-16 Schering Ag Uv stable transdermal therapeutic plaster
EP1452173A1 (de) * 2003-02-25 2004-09-01 Schering AG UV-stabiles transdermales Pflaster
BRPI0414249B1 (pt) * 2003-09-11 2013-08-06 dispersão polimérica aquosa concentrada, processo para a preparação da referida dispersão, pó de polímero, composição estabilizada e de revestimento em pó estabilizada, bem como uso da referida dispersão de polímero e do pó de polímero

Also Published As

Publication number Publication date
SI1879560T1 (sl) 2015-01-30
EP1879560A2 (de) 2008-01-23
DOP2006000100A (es) 2007-01-31
CA2605112A1 (en) 2006-11-09
DK1879560T3 (en) 2014-11-24
AU2006243442A1 (en) 2006-11-09
IL186945A0 (en) 2008-02-09
KR101426218B1 (ko) 2014-08-05
JP5360877B2 (ja) 2013-12-04
PT1879560E (pt) 2014-11-19
MX2007013779A (es) 2008-01-22
PL1879560T3 (pl) 2015-02-27
CN101171001A (zh) 2008-04-30
EP1879560B1 (de) 2014-08-27
WO2006117139A3 (de) 2007-04-19
EP1719504A1 (de) 2006-11-08
JP2008540352A (ja) 2008-11-20
NO20076187L (no) 2007-11-30
CN108969507A (zh) 2018-12-11
GT200600183A (es) 2007-01-03
CR9483A (es) 2008-01-21
ES2523663T3 (es) 2014-11-28
EA200702344A1 (ru) 2008-12-30
BRPI0611087A2 (pt) 2010-08-03
AR055927A1 (es) 2007-09-12
WO2006117139A2 (de) 2006-11-09
CA2605112C (en) 2013-11-05
KR20080003854A (ko) 2008-01-08
CY1115757T1 (el) 2017-01-25
JP2013177451A (ja) 2013-09-09
UY29511A1 (es) 2006-08-31
KR20130099203A (ko) 2013-09-05
KR101351161B1 (ko) 2014-01-14
ZA200710418B (en) 2009-08-26
TW200719902A (en) 2007-06-01

Similar Documents

Publication Publication Date Title
PE20041028A1 (es) Sistema terapeutico transdermico estable a los rayos uv
ES2670227T3 (es) Sistema terapéutico transdérmico para la administración de rivastigmina o sus derivados
PE20061414A1 (es) Sistema terapeutico transdermico solido con absorbedor uv
HRP20191048T1 (hr) Transdermalni sustavi koji onemogućavaju zloupotrebu i pogrešnu upotrebu
ES2209892T3 (es) Estratificado de material compuesto y procedimiento para su fabricacion.
NO333525B1 (no) Preparat for transdermal levering av fentanyl
ES2114423B1 (es) Nuevas composiciones farmaceuticas de liberacion de farmaco controlada por difusion-osmosis y procesos para preparar las mismas.
NO20004859D0 (no) Transdermale, terapeutiske systemer (TTS) inneholdende pergolid
ES2062093T3 (es) Emplasto de varias capas.
RU2019105280A (ru) Трансдермальные системы доставки мемантина
DE602005016812D1 (de) Zusammensetzung, enthaltend ethylen-acrylat-copolymer und polyolefine und klebrigmacher
ES2570454T3 (es) Sistema de liberación controlada de morfina
CN1545407A (zh) 含有活性物质芬太尼的透皮治疗体系(tts)
DE50103257D1 (de) Absorptionsmittel und kanalbildner enthaltende wirkstoffundurchlässige deckschicht oder abziehbare schutzschicht eines transdermalen therapeutischen systems
RS54173B1 (en) TRANSDERMAL THERAPY SYSTEM FOR ACTIVE SUBSTANCE
CA2457401A1 (en) Transdermal therapeutic system containing fentanyl or related substances
ES2579634T3 (es) Parche adhesivo médico
JP2019522025A5 (es)
DK1150662T3 (da) Laminater indeholdende aktivt stof til transdermale systemer
ES2576459T3 (es) Estructura de envasado de parche
JP2004529890A5 (es)
CN104043127A (zh) 用于增强药物的经皮吸收的组合物和贴片制剂
PT1152751E (pt) Sistema terapeutico transdermal de desoxipeganina
ES2174492T3 (es) Sistema de administracion transdermica con escopolamina base como principio activo.
KR101148315B1 (ko) 피복 박편상에 방벽 효과를 지닌 오르모서를 포함하는 피부 또는 경피성 치료학적 제제

Legal Events

Date Code Title Description
FC Refusal